Stocks and Investing
Stocks and Investing
Thu, August 18, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Kevin Fischbeck Maintained (UHS) at Sell with Increased Target to $109 on, Aug 18th, 2022
Kevin Fischbeck of B of A Securities, Maintained "Universal Health Services, Inc." (UHS) at Sell with Increased Target from $106 to $109 on, Aug 18th, 2022.
Kevin has made no other calls on UHS in the last 4 months.
There are 13 other peers that have a rating on UHS. Out of the 13 peers that are also analyzing UHS, 5 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Whit Mayo of "SVB Leerink" Maintained at Hold with Increased Target to $111 on, Thursday, July 28th, 2022
- Frank Morgan of "RBC Capital" Maintained at Hold with Decreased Target to $114 on, Wednesday, July 27th, 2022
- Joseph France of "Loop Capital" Initiated at Hold and Held Target at $115 on, Friday, June 17th, 2022
- Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $135 on, Wednesday, April 27th, 2022
- Ben Hendrix of "RBC Capital" Maintained at Hold with Decreased Target to $130 on, Wednesday, April 27th, 2022
These are the ratings of the 8 analyists that currently disagree with Kevin
- Steven Valiquette of "Barclays" Maintained at Sell with Decreased Target to $115 on, Friday, July 29th, 2022
- Jason Cassorla of "Citigroup" Maintained at Strong Buy with Decreased Target to $141 on, Wednesday, July 27th, 2022
- Andrew Mok of "UBS" Maintained at Strong Sell with Increased Target to $105 on, Tuesday, July 26th, 2022
- Jamie Perse of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $110 on, Tuesday, July 12th, 2022
- Matt Borsch of "BMO Capital" Downgraded from Hold to Sell and Held Target at $90 on, Wednesday, July 6th, 2022
- Ann Hynes of "Mizuho" Maintained at Strong Buy with Decreased Target to $121 on, Friday, July 1st, 2022
- A.J. Rice of "Credit Suisse" Maintained at Buy with Decreased Target to $141 on, Friday, July 1st, 2022
- Stephen Baxter of "Wells Fargo" Maintained at Sell with Decreased Target to $118 on, Thursday, April 28th, 2022
Contributing Sources